North America
23andMe Fiscal Q4 Revenues Increase 14 Percent
23andMe benefitted from the November acquisition of Lemonaid Health and from higher research services subscriptions.
Domus Diagnostics to Launch Point-of-Care Infectious Disease Molecular Diagnostics Test System
Premium
The Park City, Utah-based firm combines RT-LAMP with lyophilization and a scalable manufacturing system for its laminate card technology that keeps costs low.
Local Coverage Determinations Roundup: Castle Bio, SkylineDx
Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx.
Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii
With paleogenetics and archaeological data, investigators profiled individuals killed by the Mount Vesuvius eruption, generating a genome sequence for one of the ancient Pompeiians.
Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.